Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Pediatric-Refractory OCD
NCT02422290Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in obsessive compulsive disorder (OCD), sponsored by New York State Psychiatric Institute. Started Mar 2015; status: completed.
02
Drugs
ketamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02422290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422290.